Federal Supply Schedule 36F79724D0206
Award Date
9/29/24
Last Date to Order
9/28/29
Federal Agency
Veterans Integrated Service Network 12
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at up to $25,000.00, is an interim agreement under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Iovance Biotherapeutics Manufacturing LLC, a for-profit organization. The contract has a period of performance lasting until October 14, 2024. No...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Dendreon Pharmaceuticals LLC, a self-certified small disadvantaged business, on June 1, 2020. The contract has a ceiling value of $5,164,550.00 and a period of performance through December 31, 2025. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and allows the VA to procure a range of pharmaceutical and hematology-related products from the contractor. The scope of...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Intrabio Inc., a small business, for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The contract has a ceiling value of $25,000 and a period of performance from February 1, 2025 to July 3, 2025. As an interim agreement, this contract provides the VA with access to Intrabio's catalog of medical products through the Federal Supply Schedule mechanism. The...
This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs to Genmab US Inc., is for the procurement of drugs, pharmaceuticals, and hematology-related products (FSC 65 I B). The contract has a ceiling value of $750,000.00 and a period of performance from November 15, 2023, to November 14, 2028. The contract was awarded on a multiple-award basis and does not utilize any set-asides. As a Federal Supply Schedule contract, it provides a streamlined procurement...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Bioxcel Therapeutics, Inc. on February 15, 2023. The contract, identified as 36F79723D0071, has a ceiling value of $2,225,000.00 and a period of performance extending to February 14, 2028. The scope of the contract includes the provision of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA's Veterans Integrated Service Network 12. This indicates that the contract is focused...